SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

10827	Companies
234890	Keywords
163749	Articles
125724	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 03/28/2025 at 07:00, 1 year 4 months ago

Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD
Dupixent approved as the first-ever biologic medicine in Japan for COPD patients based on pivotal phase 3 results in adults with elevated eosinophils, marking a new treatment approach for COPD

Japan COPD Dupixent Phase 3 Results Biologic Medicine
PRESS RELEASE

published on 03/28/2025 at 07:00, 1 year 4 months ago

Communiqué de presse : Le Dupixent devient le tout premier biomédicament approuvé au Japon pour le traitement de la BPCO
Le Dupixent est le premier biomédicament approuvé au Japon pour traiter la BPCO, avec des résultats positifs provenant d'études de phase III. Paris, New York - 28 mars 2025

Japon BPCO Dupixent Étude De Phase III Biomédicament
PRESS RELEASE

published on 03/24/2025 at 19:27, 1 year 4 months ago

Sanofi : Déclaration des transactions sur actions propres
PRESS RELEASE

published on 03/24/2025 at 19:27, 1 year 4 months ago

Sanofi: Disclosure of trading in own shares
BRIEF

published on 03/24/2025 at 07:35, 1 year 4 months ago

Mise en ligne du document « Q1 2025 Aide mémoire » par Sanofi

Résultats Financiers Investisseurs Sanofi Aide Mémoire Q1 2025
BRIEF

published on 03/24/2025 at 07:35, 1 year 4 months ago

Sanofi launches the “Q1 2025 Aide mémoire” document

Financial Results Investors Sanofi Q1 2025 Memory Aid
PRESS RELEASE

published on 03/24/2025 at 07:30, 1 year 4 months ago

Communiqué de presse : Mise en ligne du document « Q1 2025 Aide mémoire »
Annonce de la mise en ligne du document 'Q1 2025 Aide mémoire' par Sanofi sur l'espace Investisseurs du site internet. Résultats du premier trimestre 2025 à venir le 24 avril 2025

Annonce Résultats Trimestriels Sanofi Q1 2025 Document En Ligne
PRESS RELEASE

published on 03/24/2025 at 07:30, 1 year 4 months ago

Press Release: Availability of the Q1 2025 Aide mémoire
Sanofi announced the availability of the Q1 2025 Aide mémoire on its website to assist in financial modeling, including non-comparable items and first quarter reminders

Sanofi Financial Modeling Aide Mémoire Q1 2025 Exclusivity Losses
PRESS RELEASE

published on 03/10/2025 at 21:09, 1 year 5 months ago

Sanofi: Disclosure of trading in own shares
PRESS RELEASE

published on 03/10/2025 at 21:09, 1 year 5 months ago

Sanofi : Déclaration des transactions sur actions propres

Accesswire

Published on 08/12/2026 at 15:42, 5 hours 58 minutes ago

Critical Elements 10,000-Meter Summer Drill Program at Rose West Resumes with Positive Results
Published on 08/12/2026 at 15:42, 5 hours 58 minutes ago

Critical Elements redémarre son programme de forage estival de 10 000 mètres à Rose Ouest avec des résultats positifs
Published on 08/12/2026 at 15:00, 6 hours 40 minutes ago

Karbon-X and Core Energy Sign Letter of Intent to Explore Commercial EV Charging Infrastructure in South America
Published on 08/12/2026 at 14:45, 6 hours 55 minutes ago

Lobe Sciences Ltd. Announces Non-Brokered Private Placement
Published on 08/12/2026 at 14:30, 7 hours 10 minutes ago

Recent Corporate Events Recap

View all ACCESSWIRE

EQS Group

Published on 08/12/2026 at 21:05, 34 minutes ago

Aurisco Pharmaceutical is the First Generic Oligonucleotide Manufacturer in the World successfully inspected by USFDA
Published on 08/12/2026 at 19:57, 1 hour 42 minutes ago

EQS-Adhoc: Hypoport SE: Hypoport SE resolves share buyback programme with a volume of up to EUR 10 million
Published on 08/12/2026 at 19:37, 2 hours 2 minutes ago

EQS-Adhoc: Brockhaus Technologies AG: Preliminary revenue for H1 2026 at €13.4 million and adjusted EBITDA at €-0.5 million; forecast for the continuing operations unchanged
Published on 08/12/2026 at 18:50, 2 hours 49 minutes ago

Holding(s) in Company
Published on 08/12/2026 at 18:29, 3 hours 11 minutes ago

Designated Persons Notifications

Les Echos

Published on 08/11/2026 at 17:45, 1 day 3 hours ago

DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 1 day 4 hours ago

Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 2 days 3 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 days 3 hours ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 17:45, 2 days 3 hours ago

Weekly share buyback

View all LES ECHOS COMFI WIRE